Antidiarrheal ligan compound A with antibacterial activity and application thereof
A technology for antidiarrheal lignans and compounds, applied in the field of medicine, can solve the problems of drug resistance of drug-resistant bacteria, increased mortality and other problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] 20Kg of Zixie Muzi was heated and refluxed with 10 times the volume fraction of 75% ethanol-water solution for 3 times, 1 hour each time, the extract was filtered, and the ethanol was recovered under reduced pressure to obtain the extract. The extract part (1009) was subjected to repeated silica gel adsorption column chromatography, and gradient elution was carried out with dichloromethane-methanol (100:1-1:100) system, and SephadexLH-20 column chromatography was performed with methanol-water (10:1-1 :10), dichloromethane-methanol (5:1-1:1) or pure methanol for elution, HPLC for gradient elution with methanol-water (5:95-95:5) system, combined with recrystallization, etc. Means separation and purification to obtain antidiarrheal lignan A.
Embodiment 2
[0028] (1) The antidiarrheal Muzi extract was chromatographed on a HPD600 macroporous resin column, followed by gradient elution with water and volume fractions of 60% ethanol, 70% ethanol, 80% ethanol, 90% ethanol and 100% ethanol;
[0029] (2) The eluate obtained in step (1) with a volume fraction of 80% ethanol was separated by silica gel column chromatography, and gradient eluted with dichloromethane:methanol 100:1, 100:4, 100:8, 100:16 (volume mixing ratio) to obtain the compound Crystallization, chemical properties and spectral data (see Table 1) identified as a lignan. Its structure is:
[0030]
Embodiment 3
[0031] Embodiment 3: the inhibitory activity of antidiarrheal lignan A to 2 kinds of bacterial strains
[0032] According to the American Clinical Laboratory Standardization Committee CLSI (formerly NCCLS) drug susceptibility test protocol, the in vitro antibacterial activity of the compound antidiarrheal lignan A was determined.
[0033] Instruments and materials:
[0034] Analytical balance for instruments and reagents; 721-2000 spectrophotometer (Shangdong Gaomi Rainbow Analytical Instrument Co., Ltd.); ZHJH-C luxury ultra-clean workbench (Shanghai Zhicheng Analytical Instrument Manufacturing Co., Ltd.); LDZX vertical pressure steam Sterilizer (Shanghai Shen'an Medical Instrument Factory); WMK-02 electric thermostat incubator (Hubei Province Huangshi Medical Instrument Factory); No. 11 MSSA (methicillin-sensitive Staphylococcus aureus); No. 27 MRSA (resistant to Methicillin and vancomycin-resistant Staphylococcus aureus); MH medium (Beijing Aoboxing Biotechnology Co., Ltd....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com